Christine McGrath

How Will The Northern Ireland Protocol Impact Pharma Companies?

How will the Northern Ireland Protocol impact companies in the pharmaceutical sector?  That is a question that we have been… Read more

Download our CMC e-book Now

Acorn Regulatory’s team of CMC, pharmacovigilance, quality, clinical and medical devices experts consistently produce articles for the sector.  In the… Read more

What You Need To Know About MRP Grouped Variations

We have written extensively on the topic of variations.  The topic of MRP Group Variations arises regularly in conversations with… Read more

Download ‘Regulatory Intelligence 6’ Now

‘Regulatory Intelligence 6’ from Acorn Regulatory looks at the latest trends and issues in the sector. You can download your… Read more

What MAH’s Need to Know About Outsourcing

The continued growth of outsourcing of manufacturing in the pharmaceutical industry and the use of more complicated supply chains means… Read more

Download ‘Regulatory Intelligence 5’ from Acorn Regulatory

We have published our latest e-book ‘Regulatory Intelligence 5’.  This edition features a number of new articles from our expert… Read more

What Are The Common Variation Validation Issues? Find Out Here

Variations are a critical part of maintaining the lifecycle of all dossiers. A variation is any change to the currently… Read more

Interpreting the CEP (Certificate of Suitability) Monograph

The issue of CEP’s (Certificate of Suitability) arises on a frequent basis.  We have extensive experience of assisting companies in… Read more

Scientific Advice Meetings – Advice for Companies

Scientific Advice Meetings are an area where clients and prospective clients consistently seek our support.  Our expert team has significant… Read more